Source link : https://www.newshealth.biz/health-news/study-characterizes-skin-toxicity-with-uveal-melanoma-rx/
TOPLINE: Nearly 80% of patients with metastatic uveal melanoma experienced skin toxicities with tebentafusp, a targeted immunotherapy, according to a study that also suggests that the presence of skin reactions is associated with improved survival. METHODOLOGY: This prospective cohort study evaluated 33 patients with metastatic uveal melanoma who were treated with tebentafusp (Kimmtrak) at the […]
Author : News Health
Publish date : 2024-09-04 09:35:57
Copyright for syndicated content belongs to the linked Source.
inHealth